Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 9.4% Above Its 50 Day Average – First News 24
|
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 9.4% Above Its 50 Day Average
First News 24 CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
